Vena cava filters: a synopsis of complications and related topics.
Deep venous thrombosis and pulmonary embolism constitute common preventable causes of morbidity and mortality. The incidence of venous thromboembolism (VTE) continues to increase. Standard anticoagulation therapy may reduce the risk of fatal PE by 75% and that of recurrent VTE by over 90%. For patients who are not candidates for anticoagulation, a vena cava filter (VCF) may be beneficial. Despite a good overall safety record, significant complications related to VCF are occasionally seen. This review discusses both procedural and non-procedural complications associated with VCF placement and use. We will also discuss VCF use in the settings of pregnancy, malignancy, and the clinical need for more than one filter.
Stawicki
S P
SP
Department of Surgery, The Ohio State University Medical Center, Columbus, OH, USA. stawicki_ace@yahoo.com
Sims
C A
CA
Sharma
R
R
Weger
N S
NS
Truitt
M
M
Cipolla
J
J
Schrag
S P
SP
Lorenzo
M
M
El Chaar
M
M
Torigian
D A
DA
Kim
P K
PK
Sarani
B
B
D000075202:Contraindications; D003287:Contrast Media / Q000009:adverse effects; D020878:Device Removal; D005548:Foreign-Body Migration; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000401:mortality; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000401:mortality; D011475:Prosthesis Failure; D011655:Pulmonary Embolism / Q000401:mortality / Q000517:prevention & control*; D015641:Radiography, Interventional; D012008:Recurrence; D013923:Thromboembolism / Q000209:etiology / Q000401:mortality; D016306:Vena Cava Filters / Q000009:adverse effects*
D003287:Contrast Media